[1]
|
中国心血管健康与疾病报告编写组. 中国心血管健康与疾病报告2021概要[J]. 心脑血管病防治, 2022, 22(4): 20-36, 40.
|
[2]
|
林炳辉. 冠心病患者同型半胱氨酸、纤维蛋白原水平与SYNTAX评分的相关性[D]: [硕士学位论文]. 广州: 南方医科大学, 2019.
|
[3]
|
谭学新. 炎症因子与冠心病合并糖尿病关系的研究进展[J]. 当代医学, 2016(1): 10-12.
|
[4]
|
许涵, 翟春丽, 李冰冰. 冠心病患者促炎因子IL-1β和抑炎因子IL-10全身与病变局部水平的关系[J]. 心肺血管病杂志, 2018, 37(11): 968-971.
|
[5]
|
Yanai, H. and Taniguchi, T. (2017) Role of HMGB1 in In-flammation and Cancer. Cytokine, 100, 100.
|
[6]
|
Rath, D., Geisler, T., Gawaz, M. and Vogel, S. (2017) HMGB1 Ex-pression Level in Circulating Platelets Is Not Significantly Associated with Outcomes in Symptomatic Coronary Artery Disease. Cellular Physiology & Biochemistry, 43, 1627-1633. https://doi.org/10.1159/000482026
|
[7]
|
Yin, J., Jin, D. and Wang, H. (2015) Serum Glycated Albumin Is Superior to Hemoglobin A1c for Correlating with HMGB1 in Coronary Artery Disease with Type 2 Diabetic Mellitus Patients. International Journal of Clinical & Experimental Medi-cine, 8, 4821-4825.
|
[8]
|
Cai, J., Wen, J., Bauer, E., et al. (2015) The Role of HMGB1 in Cardiovascular Biology: Dan-ger Signals. Antioxidants & Redox Signaling, 23, 1351-1369. https://doi.org/10.1089/ars.2015.6408
|
[9]
|
张岳雯, 王小敏, 刘长江, 等. 不稳定型心绞痛患者血清HMGB1的水平及临床意义[J]. 河北医药, 2015, 37(24): 3748-3750. https://doi.org/10.3969/j.issn.1002-7386.2015.24.022
|
[10]
|
Pellegrini, L., Foglio, E., Pontemezzo, E., Germani, A., Russo, M.A. and Limana, F. (2019) HMGB1 and Repair: Focus on the Heart. Pharmacology and Thera-peutics, 196, 160-182. https://doi.org/10.1016/j.pharmthera.2018.12.005
|
[11]
|
Zhao, F., Zhang, R., Zhao, H., et al. (2019) Relationship between Serum Levels of Osteoproteins, Inflammatory Cytokines and Coronary Heart Disease and Disease Severity. Chinese Critical Care Medicine, 31, 588-593.
|
[12]
|
谢明斌, 徐正明, 李倩晓, 吴源鸿, 黄琪. 冠心病患者血清补体C1q、IMA及MCP-1的表达及与冠状动脉狭窄的相关性分析[J]. 现代实用医学, 2021, 33(1): 26-28.
|
[13]
|
韩霜. MCP-1和FKN水平与冠心病患者冠状动脉病变程度的相关性分析[J]. 中国民康医学, 2021, 33(19): 109-110, 113.
|
[14]
|
赵晨, 刘红丽, 李国伟. 血清salusin-β和MCP-1表达与高血压患者发生冠心病的相关性分析[J]. 中国循证心血管医学杂志, 2021, 13(1): 109-112.
|
[15]
|
Wu, Y., Wang, L., Zhan, Y., et al. (2022) The Ex-pression of SAH, IL-1β, Hcy, TNF-α and BDNF in Coronary Heart Disease and Its Relationship with the Severity of Coronary Stenosis. BMC Cardiovascular Disorders, 22, Article No. 101. https://doi.org/10.1186/s12872-021-02388-6
|
[16]
|
Dong, Y., Chen, H.W., Gao, J.J., et al. (2019) Molecular Ma-chinery and Interplay of Apoptosis and Autophagy in Coronary Heart Disease. Journal of Molecular and Cellular Car-diology, 136, 27-41.
https://doi.org/10.1016/j.yjmcc.2019.09.001
|
[17]
|
梁琳琳. 血清炎症因子对冠心病相关致病机制的研究进展[J]. 医学理论与实践, 2018, 31(3): 335-336.
|
[18]
|
Nunes, J.P.S., Andrieux, P., Brochet, P., et al. (2021) Co-Exposure of Cardiomyocytes to IFN-γ and TNF-α Induces Mitochondrial Dysfunction and Nitro-Oxidative Stress: Implications for the Pathogenesis of Chronic Chagas Disease Cardiomyopath. Frontiers in Immunology, 12, Article 755862. https://doi.org/10.3389/fimmu.2021.755862
|
[19]
|
李国敏. 血清IL-6、TNF-α、MCP-1联合检测在冠心病临床诊断中的应用价值[J]. 检验医学与临床, 2019, 16(24): 3683-3685.
|
[20]
|
袁奇. 老年冠心病外周血清中miR-192-5p及TNF-α的表达水平及临床意义[J]. 实用老年医学, 2020, 34(6): 573-575.
|
[21]
|
Numakawa, T., Suzuki, S., Ku-mamaru, E., et al. (2010) BDNF Function and Intracellular Signaling in Neurons. Histology & Histopathology, 25, 237-258.
|
[22]
|
Wang, C.S., Kavalali, E.T. and Monteggia, L.M. (2022) BDNF Signaling in Context: From Synaptic Regulation to Psychiatric Disorders. Cell, 185, 62-76. https://doi.org/10.1016/j.cell.2021.12.003
|
[23]
|
Akbari, M., Gholipour, M., Hussen, B.M., et al. (2022) Expression of BDNF-Associated lncRNAs in Parkinson’s Disease. Meta-bolic Brain Disease, 37, 901-909. https://doi.org/10.1007/s11011-022-00946-1
|
[24]
|
Jin, H., Chen, Y.F., Wang, B.L., et al. (2018) Association between Brain-Derived Neurotrophic Factor and von Willebrand Factor Levels in Patients with Stable Coronary Artery Disease. BMC Cardiovascular Disorders, 18, Article No. 23. https://doi.org/10.1186/s12872-018-0762-z
|
[25]
|
Bi, C., Fu, Y.L., Zhang, Z.Q. and Li, B. (2020) Prostaglandin E2 Confers Protection against Diabetic Coronary Atherosclerosis by Stimulating M2 Macrophage Polarization via the Acti-vation of the CREB/BDNF/TrkB Signaling Pathway. The FASEB Journal, 34, 7360-7371. https://doi.org/10.1096/fj.201902055R
|
[26]
|
Oikawa, H., Miyazaki, S., Kurata, R., et al. (2020) Eucommia Leaf Ex-tract Induces BDNF Production in Rat Hypothalamus and Enhances Lipid Metabolism and Aerobic Glycolysis in Rat Liver. Current Molecular Pharmacology, 14, 234-244. https://doi.org/10.2174/1874467213666200505094631
|
[27]
|
Sustar, A., Perkovic, M.N., Erjavec, G.N., Strac, D.S. and Pivac, N. (2019) Association between Reduced Brain-Derived Neurotrophic Factor Concentration & Coronary Heart Disease. The Indian Journal of Medical Research, 150, 43-49.
https://doi.org/10.4103/ijmr.IJMR_1566_17
|
[28]
|
Pothineni, N.V.K., Subramany, S., Kuriakose, K., et al. (2017) Infections, Atherosclerosis, and Coronary Heart Disease. European Heart Journal, 38, 3195-3201. https://doi.org/10.1093/eurheartj/ehx362
|
[29]
|
Muscella, A., Stefàno, E. and Marsigliante, S. (2020) The Effects of Exercise Training on Lipid Metabolism and Coronary Heart Disease. American Journal of Physiology-Heart and Circu-latory Physiology, 319, H76-H88.
https://doi.org/10.1152/ajpheart.00708.2019
|
[30]
|
Xia, F., Zeng, Q.R. and Chen, J. (2022) Circulating Brain-Derived Neurotrophic Factor Dysregulation and Its Linkage with Lipid Level, Stenosis Degree, and Inflammatory Cytokines in Coronary Heart Disease. Journal of Clinical Laboratory Analysis, 36, e24546. https://doi.org/10.1002/jcla.24546
|
[31]
|
宋智斌, 高振河. 冠心病患者血清BDNF、Ghrelin、TIMP-4、FFA的水平及其与病变程度的相关性[J]. 中国卫生工程学, 2021, 20(1): 103-105, 108.
|
[32]
|
Agrimi, J., Spalletti, C., Baroni, C., et al. (2019) Obese Mice Exposedto Psychosocial Stress Display Cardiac and Hippocampal Dysfunction Associated with Local Brainderived Neurotrophic Factor Depletion. eBioMedicine, 47, 384-401. https://doi.org/10.1016/j.ebiom.2019.08.042
|
[33]
|
Sefidgari-Abrasi, S., et al. (2021) From the Gut to the Heart: L. plantarum and Inulin Administration as a Novel Approach to Control Cardiac Apoptosis via 5-HT2B and TrkB Recep-tors in Diabetes. Clinical Nutrition, 40, 190-201.
https://doi.org/10.1016/j.clnu.2020.05.004
|
[34]
|
Santamaria, S. and de Groot, R. (2020) ADAMTS Proteases in Cardiovascular Physiology and Disease. Open Biology, 10, Article ID: 200333. https://doi.org/10.1098/rsob.200333
|
[35]
|
Kelwick, R., Desanlis, I., Wheeler, G.N. and Edwards, D.R. (2015) The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin Motifs) Family. Genome Biology, 16, Article No. 113.
https://doi.org/10.1186/s13059-015-0676-3
|
[36]
|
Asano, K., Edamatsu, M., Hatipoglu, O.F., et al. (2018) Host-Produced ADAMTS4 Inhibits Early-Stage Tumor Growth. Acta Medica Okayama, 72, 257-266.
|
[37]
|
Novak, R., Hrkac, S., Salai, G., Bilandzic, J., Mitar, L. and Grgurevic, L. (2022) The Role of ADAMTS-4 in Atherosclerosis and Vessel Wall Abnormalities. Journal of Vascular Research, 59, 69-77. https://doi.org/10.1159/000521498
|
[38]
|
Rienks, J.M.M. (2018) The Emerging Role of the ADAMTS Family in Vascular Diseases. Circulation Research: A Journal of the American Heart Association, 123, 1279-1281. https://doi.org/10.1161/CIRCRESAHA.118.313737
|
[39]
|
Salter, R.C., Ashlin, T.G., Kwan, A.P.L. and Ramji, D.P. (2010) ADAMTS Proteases: Key Roles in Atherosclerosis? Journal of Molecular Medicine, 88, 1203-1211. https://doi.org/10.1007/s00109-010-0654-x
|
[40]
|
Wight, T.N. (2016) Provisional Matrix: A Role for Versican and Hyaluronan. Matrix Biology, 60-61, 38-56.
https://doi.org/10.1016/j.matbio.2016.12.001
|
[41]
|
Koch, C.D., Lee, C.M. and Apte, S.S. (2020) Aggrecan in Car-diovascular Development and Disease. Journal of Histochemistry and Cytochemistry, 68, 777-795. https://doi.org/10.1369/0022155420952902
|
[42]
|
Santamaria, S., Yamamoto, K., Teraz-Orosz, A., et al. (2019) Ex-osites in Hypervariable Loops of ADAMTS Spacer Domains Control Substrate Recognition and Proteolysis. Scientific Reports, 9, Article No. 10914.
https://doi.org/10.1038/s41598-019-47494-w
|
[43]
|
Chen, L.M., Yang, L., Zha, Y.P. and Cui, L.Q. (2011) Associa-tion of Serum a Disintegrin and Metalloproteinase with Thrombospodin Motif 4 Levels with the Presence and Severity of Coronary Artery Disease. Coronary Artery Disease, 22, 570-576. https://doi.org/10.1097/MCA.0b013e32834c7565
|
[44]
|
Uluçay, S., Çam, F.S., Batır, M.B., Sütçü, R., Bayturan, Ö. and Demircan, K. (2015) A Novel Association between TGFb1 and ADAMTS4 in Coronary Artery Disease: A New Potential Mechanism in the Progression of Atherosclerosis and Diabetes. Anatolian Journal of Cardiology, 15, 823-829. https://doi.org/10.5152/akd.2014.5762
|
[45]
|
Karakose, M., Caliskan, M., Arslan, M.S., et al. (2017) Association of ADAMTS4 and ADAMTS9 Levels with Cardiovascular Risk in Patients with Primary Hyperparathyroidism. Endocrine Research, 42, 15-20.
https://doi.org/10.1080/07435800.2017.1368543
|
[46]
|
Ozler, S., Isci Bostanci, E, Oztas, E., Kuru Pekcan, M., Gumus Guler, B. and Yilmaz, N. (2018) The Role of ADAMTS4 and ADAMTS9 in Cardiovascular Disease in Prema-ture Ovarian Insufficiency and Idiopathic Hypogonadotropic Hypogonadism. Journal of Endocrinological Investigation, 41, 1477-1483.
https://doi.org/10.1007/s40618-018-0948-3
|